This prospective cohort enrolled 602 participants (mean age 51 years; 46% women) within eight months of a premature myocardial infarction (MI). All participants underwent 99mTc-sestamibi myocardial perfusion imaging at rest and after a standardized mental stress task to detect ischemia induced by psychological stress. Mental stress-induced myocardial ischemia (MSIMI) was operationalized using a summed difference score threshold provided in the study.
MSIMI was defined in this study as a summed difference score ≥3 on myocardial perfusion imaging comparing stress to rest. MSIMI was observed more often in women than in men: 19.2% of women versus 13.2% of men, a statistically significant difference (p=0.04). The study therefore identifies a higher prevalence of stress-triggered ischemia in women after premature MI within this cohort.
The primary endpoint was a composite of cardiovascular death or nonfatal MI. A secondary endpoint expanded the primary endpoint to include heart failure hospitalization. Participants were followed for a median of 34.2 months. During follow-up there were 51 primary endpoint events and 91 secondary endpoint events across the cohort.
In sex-stratified analyses, MSIMI was associated with increased risk of the primary endpoint in both sexes, with a stronger and statistically significant association in women. The hazard ratio (HR) for the primary endpoint associated with MSIMI was 3.2 (95% CI, 1.3–7.6) in women and 1.9 (95% CI, 0.8–4.5) in men. The reported p-value for interaction by sex was 0.41. Multivariable adjustment for sociodemographic, clinical, and psychiatric factors did not materially change these associations in the presented analyses.
The authors estimated adjusted population attributable fractions to quantify the contribution of MSIMI to risk in each sex. For women the adjusted population attributable fraction for the primary endpoint was 27.6% (99% CI, 3.9%–36.9%), indicating that over one quarter of events could be statistically attributed to MSIMI in this sample. For men the adjusted fraction was 11.1% (99% CI, ?5.8%–18.4%). These estimates reflect the modeled contribution of MSIMI after adjustment; confidence intervals and negative lower bounds in men indicate uncertainty in the estimate.
In exploratory analyses the authors report that all MSIMI-related primary endpoint events among women occurred in Black women. In this subgroup the hazard ratio for the primary endpoint was 4.3 (95% CI, 1.7–11.1). These race-stratified results are presented as exploratory and point to potentially elevated risk among Black women in this cohort.
To explore mechanisms, the study measured peripheral microvascular reactivity using reactive hyperemia index (RHI) and inflammatory response to stress using interleukin-6 (IL-6). Although these measures were assessed as potential mediators, the reported analyses found that IL-6 and RHI responses did not attenuate the observed associations between MSIMI and cardiovascular outcomes.
Cox proportional hazards models adjusted for sociodemographic characteristics, clinical covariates, and psychiatric history were used to estimate associations. Associations between MSIMI and the secondary endpoint (cardiovascular death or nonfatal MI plus heart failure hospitalization) were reported to be weaker than for the primary endpoint and were attenuated after multivariable adjustment.
Within this cohort of patients recovering from premature MI, MSIMI was more common in women and was associated with an approximately threefold increased hazard of cardiovascular death or nonfatal MI among women. The authors emphasize that MSIMI accounted for a substantial adjusted population attributable fraction of events in women (about 27.6%). Exploratory findings identified Black women as a subgroup at particularly high risk in this sample. The study highlights the potential clinical importance of emotional and psychosocial triggers of ischemia after MI, particularly in women.
This report is a preprint of a single cohort study and the authors note that larger studies are needed to confirm sex differences, to better quantify attributable risk, and to investigate underlying mechanisms. The source reports that IL-6 and RHI did not explain the associations here, but mechanistic pathways remain incompletely defined. The findings should be interpreted in the context of the study design and pending peer review. Data availability is stated as obtainable from the corresponding author on reasonable request.